These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30474257)

  • 21. [The expression of Rho/Rho kinase of cardiac muscle in heart failure rats caused by pressure overload and the intervention of fasudil].
    Zhang M; Qu C; Zeng DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):73-6. PubMed ID: 15924788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-[(11)C]-methyl-hydroxyfasudil is a potential biomarker of cardiac hypertrophy.
    Moreau S; DaSilva JN; Valdivia A; Fernando P
    Nucl Med Biol; 2015 Feb; 42(2):192-7. PubMed ID: 25451216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis.
    Del Re DP; Miyamoto S; Brown JH
    J Biol Chem; 2007 Mar; 282(11):8069-78. PubMed ID: 17234627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasudil, a Rho-Associated Coiled Coil-Forming Protein Kinase Inhibitor, Recovers Methylmercury-Induced Axonal Degeneration by Changing Microglial Phenotype in Rats.
    Fujimura M; Usuki F; Nakamura A
    Toxicol Sci; 2019 Mar; 168(1):126-136. PubMed ID: 30462329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.
    Hu S; Cheng M; Guo X; Wang S; Liu B; Jiang H; Huang C; Wu G
    J Cell Mol Med; 2019 Apr; 23(4):2505-2516. PubMed ID: 30680929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-apoptotic efficacy of Qingnao Yizhi formula in hypoxia/reoxygenation primary cortical neurons through the promotion of synaptic plasticity by modulating the NogoA-Nogo receptor/Rho-Rho kinase signaling pathway.
    Qin X; Liu Y; Wu Y; Wang S; Wu H; Zhu J
    J Tradit Chin Med; 2021 Feb; 41(1):59-67. PubMed ID: 33522198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
    Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
    Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes.
    Zeidan A; Javadov S; Karmazyn M
    Cardiovasc Res; 2006 Oct; 72(1):101-11. PubMed ID: 16901475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro.
    Xiang C; Yan Y; Zhang D
    J Pharmacol Sci; 2021 Jan; 145(1):6-15. PubMed ID: 33357780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rho-associated kinase and zipper-interacting protein kinase, but not myosin light chain kinase, are involved in the regulation of myosin phosphorylation in serum-stimulated human arterial smooth muscle cells.
    Deng JT; Bhaidani S; Sutherland C; MacDonald JA; Walsh MP
    PLoS One; 2019; 14(12):e0226406. PubMed ID: 31834925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
    Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
    Miyamoto S; Del Re DP; Xiang SY; Zhao X; Florholmen G; Brown JH
    J Cardiovasc Transl Res; 2010 Aug; 3(4):330-43. PubMed ID: 20559774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of a direct cellular protective effect of Rho-kinase inhibitors on endothelin-induced cardiac myocyte hypertrophy.
    Satoh S; Kawasaki K; Ikegaki I; Asano T; Shimokawa H
    Biochem Biophys Res Commun; 2012 Jul; 424(2):338-40. PubMed ID: 22771803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, improves cognitive impairments induced by smoke exposure.
    Xueyang D; Zhanqiang M; Chunhua M; Kun H
    Oncotarget; 2016 Nov; 7(48):78764-78772. PubMed ID: 27791202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin alleviates left ventricular remodeling in isoproterenol-induced chronic heart failure in rats by regulating the RhoA/Rho kinase signaling pathway.
    Sun D; Zhang F; Ma T; Zhang Y; Liang Z
    Pharmacol Rep; 2020 Aug; 72(4):903-911. PubMed ID: 32144744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of optimized new Shengmai powder on cardiomyocyte apoptosis and ferroptosis in ischemic heart failure rats: The mediating role of phosphatidylinositol-3-kinase/protein kinase B/tumor protein 53 signaling pathway.
    Zhang ZY; Yang ZH; Wang S; Feng SL; Wang XL; Mao JY
    J Ethnopharmacol; 2024 Aug; 330():118264. PubMed ID: 38692417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-β1 promotes pulmonary arterial hypertension in rats via activating RhoA/ROCK signaling pathway.
    Zhang Y; Yuan RX; Bao D
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4988-4996. PubMed ID: 32432762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquiritigenin alleviates doxorubicin-induced chronic heart failure via promoting ARHGAP18 and suppressing RhoA/ROCK1 pathway.
    Xu Z; Hu Z; Xu H; Zhang L; Li L; Wang Y; Zhu Y; Yang L; Hu D
    Exp Cell Res; 2022 Feb; 411(2):113008. PubMed ID: 34990617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.